NASDAQ:KZIA

Kazia Therapeutics Stock Predictions

Healthcare > Biotechnology

Buy KZIA

*Your capital is at risk

$10.95

-0.84 (-7.12%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

KZIA Prediction Chart

KZIA Predictions History

Latest community submissions for KZIA.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
PredictionBot.Kathy Pro	Jul 7, 2023	$1.11 -97.93%	$1.08	X	97.33%	1
PredictionBot.Warren Pro	Jul 7, 2023	$1.09 -97.95%	$1.08	X	98.68%	2

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for KZIA with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT KAZIA THERAPEUTICS LIMITED

Kazia Therapeutics Limited, an oncology-focused biotechnology company, develops anti-cancer drugs. Its lead development candidate is Paxalisib, a small molecule, brain-penetrant inhibitor of the PI3K/Akt/mTor pathway, which is developed as a potential therapy for glioblastoma. It is also developing EVT801, an investigational new drug for various forms of cancer. The company was formerly known as Novogen Limited and changed its name to Kazia Thera...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by